1. Home
  2. NXT vs KRYS Comparison

NXT vs KRYS Comparison

Compare NXT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nextracker Inc.

NXT

Nextracker Inc.

N/A

Current Price

$79.03

Market Cap

13.6B

Sector

Technology

ML Signal

N/A

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

N/A

Current Price

$327.51

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NXT
KRYS
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.6B
9.6B
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
NXT
KRYS
Price
$79.03
$327.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
29
12
Target Price
$139.18
★ $392.11
AVG Volume (30 Days)
★ 1.6M
204.3K
Earning Date
10-22-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
10.66
★ 128.00
EPS
1.07
★ 3.62
Revenue
★ $3,559,390,000.00
$389,130,000.00
Revenue This Year
$22.05
$31.33
Revenue Next Year
$19.40
$27.55
P/E Ratio
★ $73.76
$93.08
Revenue Growth
20.28
★ 33.94
52 Week Low
$74.91
$179.16
52 Week High
$163.13
$382.54

Technical Indicators

Market Signals
Indicator
NXT
KRYS
Relative Strength Index (RSI) 37.32 41.98
Support Level N/A $331.79
Resistance Level $87.82 $371.16
Average True Range (ATR) 3.29 9.85
MACD 0.23 -1.37
Stochastic Oscillator 12.85 17.44

Price Performance

Historical Comparison
NXT
KRYS

About NXT Nextracker Inc.

Nextpower (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextpower's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextpower has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: